Received: 2 November 2020
Accepted: 6 February 2021
First Online: 27 February 2021
Ethics approval and consent to participate
: The study was approved by the Medical Ethics Committee of the Hôpital Avicenne with the Reference Number: CLEA-2020-146.
: Informed written consent was obtained from the patients for publication of this article and any accompanying images.
: JRZ reports personal fees from Pfizer, personal fees from Correvio, personal fees from Eumedica, personal fees from Merck Sharp and Dohme, outside the submitted work. NB, OM, MB, VL, NE, PK, YTL, GVDM, JO, MS, MG, AW, PA, SG ang YC report no conflict of interest.